What Ocumetra does

Ocumetra is a Dublin-based digital health company that develops the mEYE Suite, a web-based software platform for evidence-based myopia management in children. The platform is built around a proprietary, population-representative database of over one million data points on refractive development, axial length, and myopia-related disease risk, accumulated over eight years and incorporating multi-ethnic data. Core products include mEYE Guide (parent-facing communication reports with QR sharing), mEYE Gauge (axial length estimation with a 95% prediction range for clinicians without biometry equipment), mEYE Score (treatment monitoring), and the forthcoming mEYE Map. An API enables integration with EHR/EMR systems and biometric devices, with Topcon Healthcare named as an integration partner. The platform is web-based, GDPR-compliant, ISO 27001:2022 certified, and available in seven languages across markets including Ireland, the UK, North America, Australia, and New Zealand.

Ocumetra generates revenue primarily through recurring subscriptions to mEYE Suite, sold on monthly or annual cycles with a one-month free trial and tiered pricing for independent practices (1-4 clinics), growing groups (5-15), networks (15-50), and large enterprises (50+ clinics). A second revenue stream comes from bespoke industry solutions and data analytics services provided to eyecare product companies such as CooperVision, Dopavision, Sightglass, and Safilens, including clinical trial support and marketing tools. Academic partnerships offer free platform access to optometry/ophthalmology students at universities including TU Dublin, University of Bradford, and Nova Southeastern, serving as a long-term adoption pipeline. Go-to-market combines product-led growth (self-serve trial, multi-language web platform) with channel partnerships through a structured four-track program spanning clinical, industry, academic, and integration partners.

The company is co-founded and led by Professor James Loughman (CEO, PhD) and Professor Ian Flitcroft (CIO, D.Phil FRCOphth), both recognized myopia researchers, supported by a management team with regulatory, software development, clinical data analysis, and strategic growth functions. The board includes representatives from Ocuco, Furthr VC, and THINC Ventures (Topcon Healthcare's CVC), reflecting a mix of strategic corporate and venture capital backing. Headcount is reported at 11-50 employees.

Name

Ocumetra

Legal name

Ocumetra Ltd.

Website

https://ocumetra.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

Ocumetra is a Dublin-based digital health company that provides the mEYE Suite, a web-based myopia management software platform serving eyecare professionals, optical networks, and eyecare product companies with predictive analytics, parent communication tools, and EHR/biometric device integrations.

Ownership category

akta.pro rank

Headquarters

HQ city

Dublin

HQ country

Ireland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Others

Revenue model

1. Software Subscription (mEYE Guide): Monthly or annual subscription service for mEYE Guide patient communication platform. Free 1-month trial available. Annual subscription includes two months free (preferred option). Easily cancellable subscriptions. Revenue is subscription-based recurring with monthly or annual billing cycles.
2. Bundled Platform Access: Annual bundle offering provides access to multiple tools (mEYE Guide, mEYE Gauge) with two months free, offering better value than monthly subscriptions. mEYE Gauge is included free with mEYE Guide subscription.
3. Bespoke Industry Solutions: Custom clinical tools, data analytics, and integration services for industry partners seeking to enhance myopia management outcomes. Revenue generated through bespoke partnership agreements with product companies requiring custom tools including myopia and presbyopia simulation tools.
4. Enterprise/Group Subscriptions: Tiered subscription models targeting different practice sizes from independent innovators (1-4 clinics) to energetic enterprises (50+ clinics), with pricing varying by organization scale. Payments processed via Stripe supporting credit cards, debit cards, digital wallets, and regional payment methods.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels8 records

Core offering

Ocumetra sells the mEYE Suite, a web-based myopia management software platform for eyecare professionals that combines parent communication tools, axial length estimation, treatment monitoring, and centile-based clinical scoring, powered by a proprietary database of over one million patient records and machine learning-based predictive modeling. The company also offers an API for EHR/EMR and biometric device integration and a partnership program delivering bespoke clinical tools, data analytics, and integration services to industry, academic, and clinical partners.

Product overview

Ocumetra offers the mEYE Suite as its core all-in-one myopia management software platform. The suite consists of interconnected modules: mEYE Guide for parent communication, mEYE Gauge for axial length estimation (free with Guide subscription), mEYE Score for treatment monitoring, and the forthcoming mEYE Map for refractive context. Additional tools include centile charts and a vision simulator. The platform is web-based and accessible on any modern browser (phone, tablet, or desktop), available globally in English, French, Spanish, Portuguese, Hebrew, Russian, and Italian. Ocumetra also provides an API for EHR/EMR and biometric device integrations, alongside a partnership program offering bespoke clinical tools, data analytics, and integration services for clinical, industry, integration, and academic partners.

Differentiator

Problem solved

Functional benefit

Brands

• mEYE Suite: An all-in-one myopia management software platform featuring modules for patient communication, axial length estimation, and clinical scoring.
• mEYE Guide
• mEYE Gauge
• mEYE Score
• mEYE Map

Products and services

• mEYE Suite All-in-one web-based myopia management platform combining patient communication, axial length estimation, and clinical scoring tools to help eyecare professionals manage childhood myopia; built on a database of over one million patient records.
• mEYE Guide Patient communication tool that creates personalized myopia management reports for children, designed for parents and accessible via QR code or link sharing from any browser; available on monthly or annual subscription.
• mEYE Gauge Axial length estimation tool for clinicians without access to biometry, delivering data-driven estimates with a 95% prediction range and comparing the child's measurements to age- and sex-matched reference values.
• mEYE Score Treatment monitoring module that provides engaging, data-driven visuals for eyecare professionals and parents to track ongoing myopia management outcomes.
• Ocumetra API API that enables EHR/EMR software providers and biometric device manufacturers to embed Ocumetra's myopia control analytics and communication tools within their own platforms, built for compatibility and security.
• Partnership Program Services Bespoke services covering custom clinical tools, data analytics, and integration delivery for industry partners (e.g. contact lens, pharmaceutical, eyecare product companies), academic institutions, and integration partners; revenue generated through bespoke partnership agreements.

Quantifiable outcome

• 75% average increase in myopia management treatment uptake and retention in practices using Ocumetra tools
• +3 more outcomes

Named customers6 records

Segments7 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability5 records

Feature7 records

Partnerships

Six partnerships are on record, tiered core and strategic.

• Topcon HealthcarecoreTechnology or IntegrationTopcon Healthcare is listed as an integration partner, collaborating on API integration of Ocumetra's myopia control analytics with Topcon's eye care technology platforms. The partnership enables seamless data exchange and enhanced clinical workflows for eyecare professionals using Topcon devices.
• OcucocoreStrategic or Co-development PartnerLeo MacCanna, CEO and founder of Ocuco (optical software company), serves on Ocumetra's Board of Directors, bringing extensive expertise in IT strategy and optical software. Ocuco has a proven track record in scaling businesses internationally in the optical/eye care software space.
• Clinical Partners NetworkcoreChannel Partner/ Reseller/ DistributorNetwork of clinical partners including Duncan Todd Opticians, FYidoctors, Hakin Group, Myopia Focus, Lynne Fernandes Optometrists, Abesami Eye, PODS, Feltham Eyecare, and others using Ocumetra tools to enhance their myopia management services. These practices serve as reference customers and channel advocates.
• Industry Partners (Eyecare Product Companies)strategicGTM or Marketing PartnerPartnerships with eyecare product companies including Dopavision, Copper Vision, Sightglass, and Safilens. These partners use Ocumetra's data analytics and marketing tools to increase product sales, engage parents and clinicians, and understand real-world treatment efficacy of their myopia management products.
• Academic PartnersstrategicStrategic or Co-development PartnerPartnerships with universities including University of Bradford, University of Alabama, Ferris State University, Nova Southeastern University, Western Health, Massachusetts College of Optometry, Technological University Dublin. These institutions provide free platform access to students for educational purposes and collaborate on research.
• Lions Eye InstitutestrategicStrategic or Co-development PartnerGareth Lingham, Clinical Data Analyst at Ocumetra, is also a postdoctoral research fellow at the Lions Eye Institute in Perth, Australia. This academic connection supports research collaboration on myopia management and outdoor activity benefits.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Essilor (EssilorLuxottica): Essilor's Stellest lens competes in the myopia management category alongside clinical support resources for prescribing ECPs. As a global optical incumbent, Essilor represents both a potential partner and a competitor with overlapping practitioner-facing software ambitions.
• CooperVision: CooperVision manufactures MiSight contact lenses for myopia management and provides clinical resources and digital tools to ECPs. As a partner using Ocumetra's analytics to support its MiSight franchise, CooperVision is a broad incumbent with overlapping patient communication and outcome-tracking capabilities.
• Bausch + Lomb: Bausch + Lomb offers myopia management contact lenses (including Bausch + Lomb Arise) and provides clinical education and digital resources to optometrists. It is a broad incumbent in the same clinical workflow as Ocumetra's mEYE Suite.
• Topcon Healthcare: Topcon is a global ophthalmic device and software company whose products (biometers, OCTs, EHR) intersect with Ocumetra's clinical workflows. Topcon is both an integration partner and a board-level investor (via THINC Ventures), positioning it as a broad incumbent collaborating in the same clinical category.
• HOYA: HOYA's MiyoSmart spectacle lens is one of the leading myopia management products globally. HOYA provides clinical support tools and educational content to ECPs, overlapping with Ocumetra's parent-communication and treatment-monitoring value proposition.

Others

• VisionWeb: VisionWeb provides practice management, electronic claims, and supplier connectivity solutions to the optical industry. It serves the same optometry and optical retail customer base, making it an adjacent ecosystem participant rather than a direct myopia analytics competitor.
• RevolutionEHR: RevolutionEHR is an electronic health record platform built specifically for optometry practices. As a complementary/adjoining technology rather than a direct competitor, it is a potential integration partner in the same ECP workflow Ocumetra targets.

Direct peers

• Treehouse Eyes: Treehouse Eyes operates a US-based network of myopia management clinics with proprietary clinical protocols and parent education tools. While service-led rather than software-led, it competes directly for the same ECP and parent attention around myopia management.
• Ocuco: Ocuco provides practice management software and EHR platforms for the optical industry. It is Ocumetra's closest software peer, sharing the same customer base of optometrists and optical retailers; Ocuco's CEO Leo MacCanna also sits on Ocumetra's board, signaling ecosystem proximity.

Emerging players

• Myopia Profile: Myopia Profile is a clinical education and digital resources platform for eye care professionals managing myopia. It addresses an overlapping audience of ECPs with content, courses, and clinical tools, partially competing with Ocumetra's practitioner-facing value.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/ocumetra
• LinkedInlinkedin.com/company/ocumetra
• Instagraminstagram.com/ocumetra
• Xx.com/OcumetraLtd

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles23 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ocumetra